Related Experiment Video
Updated: May 24, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma
Kwong-Him To1, Sanja Pajovic, Brenda L Gallie
1Campbell Family Institute for Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
Background:
Most human cancers show inactivation of both pRB- and p53-pathways. While retinoblastomas are initiated by loss of the RB1 tumor suppressor gene, TP53 mutations have not been found. High expression of the p53-antagonist MDM2 in human retinoblastomas may compromise p53 tumor surveillance so that TP53 mutations are not selected for in retinoblastoma tumorigenesis. We previously showed that p14ARF protein, which activates p53 by inhibiting MDM2, is low in retinoblastomas despite high mRNA expression.
Methods:
In human fetal retinas, adult retinas, and retinoblastoma cells, we determined endogenous p14ARF mRNA, ARF protein, and miR-24 expression, while integrity of p53 signalling in WERI-Rb1 cells was tested using an adenovirus vector expressing p14ARF. To study p14ARF biogenesis, retinoblastoma cells were treated with the proteasome inhibitor, MG132, and siRNA against miR-24.
Results:
In human retinoblastoma cell lines, p14ARF mRNA was disproportionally high relative to the level of p14ARF protein expression, suggesting a perturbation of p14ARF regulation. When p14ARF was over-expressed by an adenovirus vector, expression of p53 and downstream targets increased and cell growth was inhibited indicating an intact p14ARF-p53 axis. To investigate the discrepancy between p14ARF mRNA and protein in retinoblastoma, we examined p14ARF biogenesis. The proteasome inhibitor, MG132, did not cause p14ARF accumulation, although p14ARF normally is degraded by proteasomes. miR-24, a microRNA that represses p14ARF expression, is expressed in retinoblastoma cell lines and correlates with lower protein expression when compared to other cell lines with high p14ARF mRNA. Transient over-expression of siRNA against miR-24 led to elevated p14ARF protein in retinoblastoma cells.
Conclusions:
In retinoblastoma cells where high levels of p14ARF mRNA are not accompanied by high p14ARF protein, we found a correlation between miR-24 expression and low p14ARF protein. p14ARF protein levels were restored without change in mRNA abundance upon miR-24 inhibition suggesting that miR-24 could functionally repress expression, effectively blocking p53 tumor surveillance. During retinal tumorigenesis, miR-24 may intrinsically compromise the p53 response to RB1 loss.
Insights
MicroRNA-24 (miR-24) represses p14ARF protein in retinoblastoma, compromising p53 tumor surveillance. Inhibiting miR-24 restores p14ARF levels, suggesting a therapeutic target for retinoblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Retinoblastomas often lack TP53 mutations despite RB1 pathway inactivation.
- High MDM2 expression in retinoblastomas may suppress p53 activity.
- Low p14ARF protein, despite high mRNA, suggests post-transcriptional regulation issues in retinoblastoma.
Purpose of the Study:
- Investigate the post-transcriptional regulation of p14ARF in retinoblastoma.
- Determine the role of microRNA-24 (miR-24) in p14ARF protein levels.
- Assess the impact of p14ARF restoration on p53 signaling and cell growth.
Main Methods:
- Quantified p14ARF mRNA, protein, and miR-24 expression in retinal tissues and retinoblastoma cells.
- Utilized proteasome inhibitor MG132 and siRNA against miR-24 to study p14ARF biogenesis.
- Employed adenovirus-mediated p14ARF overexpression to assess p53 pathway integrity.
Main Results:
- Retinoblastoma cells exhibit disproportionately high p14ARF mRNA relative to protein levels.
- Overexpression of p14ARF reactivated p53 signaling and inhibited cell growth.
- miR-24 expression correlated with lower p14ARF protein; miR-24 inhibition elevated p14ARF protein without altering mRNA levels.
Conclusions:
- miR-24 functionally represses p14ARF protein expression in retinoblastoma.
- This miR-24-mediated repression compromises p53 tumor surveillance.
- Targeting miR-24 may restore p53 function and offer a therapeutic strategy for retinoblastoma.
Related Concept Videos
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
